Kiyoshi Yoshino
Biographic Data
| ID | 7409589 |
|---|---|
| NAME | Kiyoshi Yoshino |
| GIVEN NAMES | Kiyoshi |
| FAMILY NAME | Yoshino |
| SIGNATURE | YOSHINO K |
| AFFILIATIONS | The University of Osaka |
| ORCID | 0000-0002-5732-5215 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2016 |
| H-INDEX | 0 |
Development of an efficient strategy to improve HPV immunization coverage in Japan
Following what we foresee as the inevitable restart of the Japanese government's recommendation for receiving the HPV vaccine, we expect to first see vaccinations occurring in a very small group of girls, the daughters of the most willing mothers, which will be roughly 4 % of those eligible for government paid vaccinations. This will be followed by the spread of vaccinations outward through these girls' circle of friends and acquaintances, and, f…
Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer
Serum tumor markers have a major role in the screening, diagnosis, and monitoring of most of the gynecologic cancers. Ovarian cancer is one of the deadliest of the group because it is so frequently asymptomatic until it has advanced to an untreatable stage. Even serum cancer antigen-125 (CA-125), clinically one of the most reliable serum markers for ovarian cancer, is elevated in only half of early-stage still-treatable tumors. Because of the ver…
No prominent works on this page.
Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer
Serum tumor markers have a major role in the screening, diagnosis, and monitoring of most of the gynecologic cancers. Ovarian cancer is one of the deadliest of the group because it is so frequently asymptomatic until it has advanced to an untreatable stage. Even serum cancer antigen-125 (CA-125), clinically one of the most reliable serum markers for ovarian cancer, is elevated in only half of early-stage still-treatable tumors. Because of the ver…
Development of an efficient strategy to improve HPV immunization coverage in Japan
Following what we foresee as the inevitable restart of the Japanese government's recommendation for receiving the HPV vaccine, we expect to first see vaccinations occurring in a very small group of girls, the daughters of the most willing mothers, which will be roughly 4 % of those eligible for government paid vaccinations. This will be followed by the spread of vaccinations outward through these girls' circle of friends and acquaintances, and, f…
Biostatistics (1 work) · Business (1 work) · Cervical Cancer and HPV Research (1 work) · Computer Science (1 work) · Daughter (1 work) · Demography (1 work) · Demography (1 work) · Disaster Management and Resilience (1 work) · Engineering (1 work) · Environmental health (1 work)